Agios Pharmaceuticals, Inc. (AGIO) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Agios Pharmaceuticals, Inc. (AGIO) - Medical Equipment - Deals and Alliances Profile

Agios Pharmaceuticals, Inc. (AGIO) - Medical Equipment - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Agios Pharmaceuticals, Inc. (AGIO) - Medical Equipment - Deals and Alliances Profile
Published Oct 18, 2016
29 pages — Published Oct 18, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Agios Pharmaceuticals, Inc. (Agios) is a biopharmaceutical company that discovers and develops investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The companys pipeline products include AG-221, an isocitrate dehydrogenase (IDH) 2 mutant inhibitor; AG-120, an IDH1 mutant inhibitor; and AG-881, a pan-IDH mutant inhibitor intended for the treatment of hematologic malignancies and solid tumors. It also develops AG-348 and AG-519, a potent activator intended for the treatment of patients with pyruvate kinase deficiency. The company has collaboration with Celgene, to enhance its product candidates.

Agios Pharmaceuticals, Inc. (AGIO) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical Equipment eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals i

  
Source:
Document ID
GDME135515D
Country
Industry
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Agios Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 201642
Agios Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2010 to YTD 201661
Agios Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 201671
Agios Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2010 to YTD 201681
Agios Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2010 to YTD 201691
Agios Pharmaceuticals, Inc., Medical Equipment, Deal Details105
  Partnerships101
    Celgene and Agios Pharma Enter into Agreement with Abbott Labs101
    Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics111
    Agios Pharma Enters Into Licensing Agreement With University of Pennsylvania121
  Equity Offering131
    Agios Pharma Raises USD150 Million in Public Offering of Shares132
Agios Pharmaceuticals, Inc. - Key Competitors151
Key Employees161
Locations And Subsidiaries171
  Head Office171
Recent Developments181
Strategy And Business Planning181
Jan 11, 2016: Agios Outlines Key 2016 Goals and Priorities182
Financial Announcements201
Aug 04, 2016: Agios Reports Second Quarter 2016 Financial Results202
May 05, 2016: Agios Reports First Quarter 2016 Financial Results222
Nov 05, 2015: Agios Reports Third Quarter 2015 Financial Results243
Corporate Communications271
Aug 16, 2016: Agios Appoints Andrew Hirsch as Chief Financial Officer271
Feb 08, 2016: Agios Appoints Steve Hoerter as Chief Commercial Officer281
Appendix291
  Methodology291
  About GlobalData291
  Contact Us291
  Disclaimer291

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Agios Pharmaceuticals, Inc. (AGIO) - Medical Equipment - Deals and Alliances Profile" Oct 18, 2016. Alacra Store. Sep 20, 2019. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Agios-Pharmaceuticals-Inc-AGIO-Medical-Equipment-Deals-and-Alliances-Profile-2148-25439>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Agios Pharmaceuticals, Inc. (AGIO) - Medical Equipment - Deals and Alliances Profile Oct 18, 2016. New York, NY: Alacra Store. Retrieved Sep 20, 2019 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Agios-Pharmaceuticals-Inc-AGIO-Medical-Equipment-Deals-and-Alliances-Profile-2148-25439>
  
US$ 250.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research